ArticleJournal of the American Chemical Society2026
Unlocking the Silent Proteome: Chemoselective Asn/Gln Activation for Multidimensional Protein Diversification.
Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-translational modification-regulating biomaterials for regeneration.Bioactive materials · 2026Review
- Expanding the Chemoproteomic Toolkit to Asparagine and Glutamine.ACS chemical biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Amides are ubiquitous in pharmaceuticals, natural products, and biomolecules, owing to their exceptional stability and hydrogen-bonding capacity. Among the amino acids, asparagine (Asn) and glutamine (Gln) contain neutral primary amide side chains and constitute over 8% of the human proteome. Despite their abundance, these residues have remained largely inaccessible to selective chemical modification due to their low intrinsic reactivity and the propensity of proteinogenic side chains to poison transition-metal catalysts via chelation. Here, we report a general strategy that converts the primary amides of Asn and Gln into bioorthogonal nitrile handles, which can be further diversified through carbometalation with aryl boronic acids to yield aryl ketone products. This transformation proceeds with exceptional chemoselectivity, enabling the modification of native peptides and proteins. We demonstrate its broad utility in the synthesis of unnatural amino acids, late-stage diversification of peptides, fluorosequencing of Asn residues, and site-selective protein modification, culminating in the synthesis of a functional antibody-fluorophore conjugate. The versatility and selectivity of this approach expand the accessible chemical space of biomolecules and provide a powerful route for uncovering previously uncharacterized Asn/Gln sites within the chemically silent proteome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.